115 related articles for article (PubMed ID: 38479132)
1. Novel chiral matrine derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
Qiu G; Li F; Kowah JAH; Xie J; Long Q; Wang L; Liu X
Bioorg Chem; 2024 May; 146():107276. PubMed ID: 38479132
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of matrine contains benzimidazole derivatives as dual TOPOI and PARP inhibitors for cancer therapy.
Qiu G; Xie J; Li F; Han K; Long Q; Kowah JAH; Gao R; Wang L; Liu X
Eur J Med Chem; 2024 Apr; 270():116348. PubMed ID: 38554475
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of the Matrine Derivatives as a Novel Family of Potential Anticancer Agents.
Wang J; Liu H; Zhuo XB; Ye GM; Zhao QJ
Med Chem; 2021; 17(5):493-500. PubMed ID: 31642790
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents.
Zhang MW; He Y; Wei MX
Eur J Med Chem; 2023 Jun; 254():115375. PubMed ID: 37084600
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
Li Z; Luo M; Cai B; Wu L; Huang M; Haroon-Ur-Rashid ; Jiang J; Wang L
Bioorg Med Chem Lett; 2018 Feb; 28(4):677-683. PubMed ID: 29395978
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
[TBL] [Abstract][Full Text] [Related]
7. New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment.
Xu Y; Jing D; Zhao D; Wu Y; Xing L; Ur Rashid H; Wang H; Wang L; Cao H
Bioorg Med Chem; 2020 Feb; 28(4):115305. PubMed ID: 31928863
[TBL] [Abstract][Full Text] [Related]
8. Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition.
Halim PA; Sharkawi SMZ; Labib MB
Bioorg Chem; 2023 Feb; 131():106273. PubMed ID: 36444790
[TBL] [Abstract][Full Text] [Related]
9. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
[TBL] [Abstract][Full Text] [Related]
10. Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells.
Tetik Vardarlı A; Düzgün Z; Erdem C; Kaymaz BT; Eroglu Z; Çetintas VB
Bosn J Basic Med Sci; 2018 May; 18(2):141-149. PubMed ID: 29045804
[TBL] [Abstract][Full Text] [Related]
11. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
Xu Y; Jing D; Chen R; Rashid HU; Jiang J; Liu X; Wang L; Xie P
Bioorg Med Chem; 2018 Aug; 26(14):4136-4144. PubMed ID: 30007563
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
14. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agents.
Wu L; Liu S; Wei J; Li D; Liu X; Wang J; Wang L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4267-71. PubMed ID: 27481558
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo.
Feng Y; Lu Y; Li J; Zhang H; Li Z; Feng H; Deng X; Liu D; Shi T; Jiang W; He Y; Zhang J; Wang Z
Eur J Med Chem; 2022 Jan; 227():113888. PubMed ID: 34628244
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis of novel chromene-based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c-Src inhibition.
Abdelall EKA; Elshemy HAH; Labib MB; Mohamed FEA
Drug Dev Res; 2024 Feb; 85(1):e22133. PubMed ID: 37971069
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
19. Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3.
Gu YY; Chen MH; May BH; Liao XZ; Liu JH; Tao LT; Man-Yuen Sze D; Zhang AL; Mo SL
Phytomedicine; 2018 Dec; 51():214-225. PubMed ID: 30466620
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors.
Sakr H; Ayyad RR; El-Helby AA; Khalifa MM; Mahdy HA
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000456. PubMed ID: 33554352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]